Protective Effects of Measles Against Cancer and Heart Disease

Posted on by

Protective Effects of Measles Against Cancer and Heart Disease

by Jeffrey Dach MD

98% Decline in Measles Mortality Before Introduction of \/axxine

Measles mortality declined by 98% over 60 years before introduction of the measles \/a<<ine. In 1963, just prior to the \/a<<ine, there were about 400 annual deaths from measles in the US. This translates to mortality rate of ONE in 450,000 Americans die from measles annually in the US. Aaron Siri says:

Yet, our health department promotes measles as if millions of Americans died before the \/a<<ine…Those who don’t get measles have a statistically significant increase in death from cardiovascular disease and cancer. A large Japanese government study over 20 years showed those who did not contract measles and mumps had a 20 percent increase in death from cardiovascular disease.(1)

If Cardiovascular disease kills 500,000 people per year, 20 percent would be 100,000 people. Two percent would be 10,000 people. And one percent would be 5,000 people. This is still way above the 400 annual deaths from measles. This inverts the public health benefit of a measles/mumps \/a<<ine.

Aaron Siri goes on to say:

In those who have had measles, this reduces Hodgkins lymphoma by 66 percent and reduces Non-Hodgkins lymphoma by 166 percent. This about 20,000 mostly kids per year. If you have had measles, you have half the rate of ovarian cancer. The studies are all in the medical literature and they are all pretty consistent, showing the same thing. From a public health perspective, did we have a net benefit [from introduction of the measles/mumps \/a<<ine ? No, we did not.] (2-7)

Here is the 3 minute video clip of Aaron Siri:

================================

Measles \/a<<ine Deaths Exceeds Measles Deaths

Another inconvenient truth is that deaths from the measles \/a<<ine exceeds deaths from contracting measles virus.

Dr. Nicholas Hulscher reviewed VAERS data since 1995 showing about 299 US death reports post-MMR \/a<<ine compared with only 7 wild measles deaths. Opponents argue that VAERS data is not causal and can not be used. I would disagree with this and in my opinion, the VAERS measles death data is valid.

Both the measles \/a<<ine and the wild type measles are live viruses and have similar adverse side effect profiles. For example, encephalitis and ITP (autoimmune destruction of platelets leading to bleeding) are listed for both.

Encephalitis

Wild-type measles: ~1 in 1,000 cases of encephalitis (high risk of permanent damage or death).

MMR vaccine: Listed as a rare reported event. We don’t know the actual numbers for certain.

ITP/Thrombocytopenia:

Wild-type measles: Estimates suggest more cases per measles infection than the ~1 in 25,000–40,000 after MMR \/axxine. The reality is we really don’t know what the actual numbers are.

\/a<<ine-associated ITP is usually thought to be self-limited.

Reference see: Hulscher, N., et al. “Deaths Following MMR and MMRV Vaccination in the United States.” Zenodo, 17 Feb. 2026.

Measles Treatment With Vitamins A and C:

Severity of the wild type measles can be reduced with use of high dose vitamin C, Vitamin A.  For those individuals who wish to minimize risk of complication from measles infection, supplemental Vitamin C and Vitamin A has been studied and shown helpful. Thomas Levy MD’s book,  “Curing the Incurable: Vitamin C, Infectious Diseases and Toxins” discusses the benefits of supplemental vitamin A and vitamin C for viral illness.

“Like polio and hepatitis, measles is one more disease that is completely curable by properly dosed Vitamin C given by the proper route. Also, when adequate dosages are ingested regularly, measles can also be prevented. Other vitamin supplementation is also a good idea. Goskowitz and Eichenfeld (1993) noted that an acute Vitamin A deficiency can be seen in children with measles, usually associated with a more severe disease. However, because Vitamin C can promptly cure a fully developed case of measles, the ability to prevent an infection is not nearly so important. In fact, a valid argument can be made that contracting the disease, curing it with Vitamin C, and then attaining the resultant long-term immunity to the disease might be the most desirable way to proceed. This is especially true since adequate Vitamin C may not always be readily available and/or there may not be a doctor willing to dose it properly when the disease strikes.” Endquote Dr Thomas Levy Levy, Thomas E. Curing the Incurable: Vitamin C, Infectious Diseases, and Toxins. Xlibris Corporation, 2002.

Suzanne Humphries MD Experience Using Vitamin C for Measles

In this short clip below, Dr. Suzanne Humphries describes her experience treating children with measles with IV vitamin C with very good results. Vitamin C for measles and other viral disease was pioneered by Dr. Frederick R. Klenner, a family physician from Reidsville, North Carolina who used oral and injectable high-dose vitamin C (ascorbic acid) for various viral infections such as measles.

Dr. Frederick R. Klenner published his case reports in the Southern Medicine and Surgery from the late 1940s and early 1950s. Many of the cases on measles originated from the 1948 measles outbreak. He described vitamin C as capable of aborting, modifying, or rapidly resolving measles symptoms, preventing complications like pneumonia or encephalitis, and acting like an “antibiotic” against viruses.

Here are a few of his published reports:

Massive Doses of Vitamin C and the Virus Diseases (1951), Journal of the International College of Surgeons* or similar proceedings).

The Use of Vitamin C as an Antibiotic” (1953), Journal of Applied Nutrition.

Virus Pneumonia and Its Treatment With Vitamin C (1948)

The Treatment of Poliomyelitis and Other Virus Diseases with Vitamin C (1949), Southern Medicine and Surgery.

Measles-Specific Cases and Observations:

Klenner experimented on his own children during a 1948 measles epidemic: He intentionally exposed his two young daughters to contagious measles cases. When symptoms appeared (fever, red eyes, cough, Koplik spots, etc.), he administered vitamin C.
– 1,000 mg every 4 hours (oral) modified the attack (milder symptoms).
– Smaller doses allowed progression.
– 1,000 mg every 2 hours cleared all evidence of infection in 48 hours.
– Stopping treatment caused symptoms to return; he observed this “on-and-off” pattern for 30 days.
– Continuous 1,000 mg every 2 hours for 4 days fully resolved it without recurrence.
– He reported treating “hard measles” (severe cases with high fever, cough, red eyes, Koplik spots):

Case Report #1 : A 10-month-old infant with pre-measles symptoms (fever to 105°F, catarrh, spasmodic cough). Given 65 mg/kg IM every 4 hours → fever dropped dramatically in 12 hours; symptoms cleared. Temporarily stopping caused rebound fever; resuming resolved it. No rash developed; child remained measles-free for 18+ months (no re-exposure).

Case Report #2 : A 22-month-old: Initial treatment aborted symptoms, but after discharge and exposure to siblings with full measles, the child developed modified measles without further vitamin C.

Case Report #3 : High doses (e.g., 350–400 mg/kg every 2 hours, often IV/IM) stopped measles progression, dried up rashes (similar to chickenpox), and prevented complications like pneumonia (which he claimed never developed with intensive therapy).

Case Report #4: A diabetic child with measles saw insulin needs spike massively; 1 g every 4 hours controlled both infection and blood sugar.
–
Case Report #5 : A combination of Measles + mumps leading to encephalitis resolved rapidly with IV/IM vitamin C (e.g., 2 g initial dose, then frequent follow-ups; stupor lifted, fever dropped, patient recovered quickly).

General Dosing Approach for Viral Illnesses (Including Measles):

– Body weight-based: Often 350–1,200 mg/kg per day, divided frequently (every 2–4 hours).
– Routes: IV preferred for severe cases (rapid high blood levels), IM or oral otherwise.
– He emphasized frequency over total daily dose to maintain saturation, as vitamin C is rapidly used/excreted in infections.
– Symptom resolution often in 24–72 hours; full recovery in days.

Dr. Klenner linked success to vitamin C neutralizing viruses directly or supporting immunity (e.g., preventing hemorrhagic complications akin to scurvy).

Key Original/Archival Sources (PDFs available online)

– 1953 paper: https://mv.helsinki.fi/home/hemila/CP/Klenner_1953_VitCAntibiotic.pdf

– 1951 virus diseases paper: https://mv.helsinki.fi/home/hemila/CP/Klenner_1951_VirusDiseases.pdf

– 1949 polio/virus paper (mentions measles context): https://mv.helsinki.fi/home/hemila/CP/Klenner_1949_Polio.pdf

– Compiled clinical guide/summary: https://vitaminc.co.nz/pdf/CLINICAL-GUIDE-TO-THE-USE-OF-VITAMIN-C-FREDERICK-KLENNER-MD.pdf

Vitamin C Prevents Pneumonia: Nutrients 2017, 9(4), 339; Vitamin C and Infections Harri Hemilä Department of Public Health, University of Helsinki Published: 29 March 2017

Safety of High Dose IV Vitamin C

Safety of IV vitamin C has been evaluated in Phase One Clinical trials in three patients with B cell lymphoma (75 grams IV ) with serum ascorbate level of greater than 15 with no adverse events. A second Clinical Trial in 35 lung cancer patients with high dose IV vitamin C , three times a week for 4 weeks, likewise showed no adverse effects. Ascorbate serum levels were recorded in the range of 15-20 mMoles/L. Both trials showed excellent safety profile with no adverse effects.

It is quite obvious high dose intravenous vitamin C is an extremely safe and beneficial therapy for viral illness, and for septic shock in the ICU. In fact, it should be offered routinely on all hospital wards along with their standard treatments. The fact that main stream medicine has rejected and ignored this inexpensive, safe and effective therapy is simply astounding. You can change things by giving your doctor a copy of this article.

Conclusion: Aaron Siri makes the case that the health benefits of wild type measles, specifically in reducing cardiovascular mortality and cancer mortality, far exceeds any possible health benefit of the measles \/a<<ine. The health benefits of contracting wild type measles are all documented in studies published in the medical literature (see references below).

Header Image: Cover of book by Aaron Siri courtesy of Elizabeth Meyer HeartStringBirthServices on Instagram.  Link to Photo on Instagram.

Articles with related interest:

Measles Outbreaks, Fake News and Mass Hysteria

Which is Greater threat Measles or Measles Vaccine?

Financial Kickbacks to Pediatricians is Illegal and Harms Children

Jeffrey Dach MD
7450 Griffin Road Suite 190
Davie, Florida 33314
954-792-4663

References

1) Japanese Cohort Study (2015) on Measles/Mumps and Cardiovascular Disease

This is the 22-year follow-up study from the Japan Collaborative Cohort (JACC) Study, involving a large sample of Japanese adults (approximately 100,000+ participants, though exact numbers in analyses vary by subgroup; often cited around 110,000 in discussions). It linked history of measles (and mumps) infections to lower mortality risks from atherosclerotic cardiovascular disease (CVD), including reductions in total CVD (e.g., ~11-20% lower in combined infections), myocardial infarction (heart attack; up to ~29% lower in some subgroups), and stroke (e.g., ~16-21% lower in certain comparisons).

Kubota Y, Iso H, Tamakoshi A; JACC Study Group. Association of measles and mumps with cardiovascular disease: The Japan Collaborative Cohort (JACC) study. Atherosclerosis. 2015 Aug;241(2):682-6.

https://www.sciencedirect.com/science/article/abs/pii/S0021915015013805

https://www.atherosclerosis-journal.com/article/S0021-9150(15)01380-5/pdf (open access via journal site in some views)

Key reported findings include hazard ratios (HR) such as 0.71 (29% reduction) for myocardial infarction in men with both infections, and overall lower atherosclerotic CVD mortality with combined measles/mumps history.

2) UK Pre-Vaccination Cohort Study (2013) on Childhood Measles and Adult Cancer Mortality

This prospective cohort used data from the Newcastle Thousand Families Study (participants born in 1947 in a pre-vaccination era for measles in the UK). It examined associations between childhood infectious diseases and premature cancer death in adulthood (ages 15-60 years), finding childhood measles history linked to reduced overall cancer mortality risk (adjusted HR 0.39, indicating ~61% lower risk in some models).

Full Citation: Tennant PWG, et al. Childhood infectious disease and premature death from cancer: a prospective cohort study. European Journal of Epidemiology. 2013 Mar;28(3):257-65.

Note: This study focused on overall cancer mortality reduction with measles and influenza history (while pertussis was associated with increased risk). It does not specifically address Hodgkin’s lymphoma (where UK studies around 2000 showed mixed/no protective effects or potential viral presence in tumors, as noted in the original summary).

These are the primary peer-reviewed sources matching the descriptions. The mortality drop claims (e.g., 98% from 1900-1963 due to sanitation/nutrition) are commonly cited in discussions (including by Aaron Siri) based on historical U.S. vital statistics data, but they are not from a single specific “study” in the referenced context—rather, they draw from public health records and graphs showing pre-vaccine declines in measles deaths (largely attributed to better supportive care, nutrition, and hygiene reducing complications like secondary infections).

3) Siri, A. (2025). Vaccines, Amen: The Religion of Vaccines. Injecting Freedom LLC. ISBN 979-8992423006 (paperback, 301 pages).

This is Aaron Siri’s own 2025 book (released September 4, 2025), in which he explicitly lays out the published studies showing that natural measles infection in childhood is statistically associated with lower rates of Hodgkin’s lymphoma, non-Hodgkin’s lymphoma, ovarian cancer, and overall cancer mortality later in life, as well as lower cardiovascular mortality. In public appearances and interviews (including the above video clip), Siri directly references these findings from the book and states that he “lays it out in my book.”

The specific lymphoma claims he discusses in the book (and in the related video/podcast clips) draw from peer-reviewed epidemiological studies such as:

The 2013 prospective cohort study (Newcastle Thousand Families Study, UK/European data) linking childhood measles infection to reduced adult cancer mortality.

Earlier case-control and cohort data (including UK-based analyses around 2000 and related European findings) showing elevated lymphoma risks in those without natural measles infection.

4) Alexander FE, Jarrett RF, Lawrence D, et al. Risk of Hodgkin’s disease associated with Epstein-Barr virus (EBV) and cytomegalovirus (CMV) and with prior EBV and CMV infection. British Journal of Cancer. 2000;82(5):1119-1123.

This UK population-based case-control study (part of broader analyses around that era) found associations consistent with a protective effect from measles infection in school-age children against Hodgkin’s disease (now called Hodgkin lymphoma).

“The present data cannot distinguish between measles and total infections but are consistent with a specific protective effect of measles in school age children.”

This implies higher relative risk in those without measles history.

5) Montella M, Crispo A, Grimaldi M, et al. Do childhood diseases affect NHL and HL risk? A case-control study from northern and southern Italy.Leukemia Research. 2006;30(8):917-922.

This Italian case-control study (225 NHL cases, 62 HL cases, 504 controls) found all examined childhood diseases negatively associated with HL, and measles negatively associated with NHL (particularly follicular B-cell NHL). It supports a potential protective effect from measles against NHL and provides evidence that common childhood infections (including measles) may lower HL risk in adulthood.

6) Parodi S, Seniori Costantini A, et al. Childhood infectious diseases and risk of non-Hodgkin’s lymphoma according to the WHO classification: A reanalysis of the Italian multicenter case-control study. International Journal of Cancer. 2020;146(4):977-986.
Inverse associations were observed for several infections (including trends with number of infections) in B-cell NHL subtypes, aligning with prior European data suggesting protective roles from childhood infections like measles.

7) Tennant PWG, Pearce MS, Bythell M, Rankin J. Childhood infectious disease and premature death from non-communicable diseases in northern England: a retrospective cohort study. European Journal of Epidemiology. 2013;28(5):415-426.

From the Newcastle Thousand Families Study (UK prospective cohort, pre-vaccination era), childhood measles was independently associated with reduced cancer mortality risk in adulthood (adjusted HR = 0.39, 95% CI 0.17-0.88). While not lymphoma-specific, it is frequently cited in discussions of measles’ potential inverse link to later cancers (including lymphomas).

Last updated on by Jeffrey Dach MD

Discover more from Jeffrey Dach MD

Subscribe to get the latest posts sent to your email.

Leave a Reply